Division of Translational Cancer Research
16 – 30 of 599
- show: 15
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2024
-
Mark
Research Protocol for an Observational Health Data Analysis on the Adverse Events of Systemic Treatment in Patients with Metastatic Hormone-sensitive Prostate Cancer : Big Data Analytics Using the PIONEER Platform
(
- Contribution to journal › Article
-
Mark
Predictive Models for Assessing Patients’ Response to Treatment in Metastatic Prostate Cancer : A Systematic Review
(
- Contribution to journal › Scientific review
-
Mark
Cellular plasticity in the breast cancer ecosystem
(
- Contribution to journal › Scientific review
-
Mark
Discovery of a small molecule that inhibits Bcl-3-mediated cyclin D1 expression in melanoma cells
(
- Contribution to journal › Article
-
Mark
Nucleoredoxin Redox Interactions Are Sensitized by Aging and Potentiated by Chronic Alcohol Consumption in the Mouse Liver
(
- Contribution to journal › Article
-
Mark
Development of celiac-safe foods : prevention of transglutaminase 2 (TG2) deamidation of gluten in healthy non-celiac volunteers
(
- Contribution to journal › Article
-
Mark
Molecular patterns of resistance to immune checkpoint blockade in melanoma
(
- Contribution to journal › Article
-
Mark
Genomic alterations in ovarian endometriosis and subsequently diagnosed ovarian carcinoma
(
- Contribution to journal › Article
-
Mark
Tumor suppressor role of the complement inhibitor CSMD1 and its role in TNF-induced neuroinflammation in gliomas
(
- Contribution to journal › Article
-
Mark
Disruption of the TP53 locus in osteosarcoma leads to TP53 promoter gene fusions and restoration of parts of the TP53 signalling pathway
(
- Contribution to journal › Article
-
Mark
European Association of Nuclear Medicine Focus 5 : Consensus on Molecular Imaging and Theranostics in Prostate Cancer
(
- Contribution to journal › Article
-
Mark
Interleukin-1 receptor accessory protein (IL-1RAP) : A magic bullet candidate for immunotherapy of human malignancies
(
- Contribution to journal › Scientific review
-
Mark
DDR1/2 enhance KIT activation and imatinib resistance of primary and secondary KIT mutants in gastrointestinal stromal tumors
(
- Contribution to journal › Article
-
Mark
Cancer-associated fibroblasts express CD1d and activate invariant natural killer T cells under cellular stress
(
- Contribution to journal › Letter
-
Mark
Therapeutic potential of miR-379 in prostate cancer
2024) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)